One Mission, One Goal: Veterans Health

About NCIRE

We are a scientific community of clinicians and researchers and we partner with the University of California, San Francisco (UCSF) and the San Francisco VA Health Care System (SFVAHCS) to bring the power of modern medicine to the health of our nation’s Veterans.

About

Research News

NCIRE CEO attends VA Research Week Kick-off Event that honors researchers

On May 9th the VA and the National Association of Veterans Research & Education Foundations (NAVREF) kicked off this year’s Research Week with Secretary Denis McDonough at the VA Headquarters in Washington, D.C.

NCIRE CEO and NAVREF Secretary Rebecca Rosales was invited to join the kick-off ceremonial event that recognized six extraordinary researchers who have been instrumental in their fields: Dr. Rory Cooper (Pittsburgh), Dr. Donna Washington (Los Angeles), Dr. Ziyad Al-Aly, (St. Louis) Dr. Elizabeth Yano (Los Angeles), Dr. Nicholas Nickols (Los Angeles) and Dr. Samantha Connolly (Boston).

Research Week, May 9th – 12th of this year, provides an opportunity to celebrate the Research Community, their achievements, and dedication to improving the health of Veterans and the population at large. Now more than ever Veterans Research needs continued support and funding to serve the more than 9 million Veterans to improve their lives through cutting-edge health care discovery and innovation.

Ms. Rosales was honored to represent NCIRE, NAVREF, and the San Francisco VA as a guest of Secretary McDonough and help celebrate the vital contributions of our nation’s research scientists.

Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity

In chronic kidney disease (CKD), assessment of both estimated glomerular filtration rate (eGFR) and albuminuria are necessary for stratifying risk and determining the need for nephrology referral.

However, NCIRE-supported investigators Drs. Michael Shlipak and Michelle Estrella, along with their research colleagues found that only half of patients meeting laboratory criteria for nephrology referral were seen by a nephrologist.

Underutilization of albuminuria testing may be a barrier to identifying primary care patients at elevated kidney failure risk who may warrant nephrology referral, a missed opportunity for vital specialized care.

Michael Shlipak, MD, MPH is the NCIRE Board Chair and Associate Chief of Medicine for Research Development at SFVAHCS, Scientific Director, Kidney Health Research Collaborative at UCSF, and Professor of Medicine, Epidemiology & Biostatistics at UCSF.

Michelle Estrella, MD, MHS is a Professor of Medicine and the Renal Section Chief at the San Francisco VA Medical Center.

Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial

Many drugs, metabolites, and toxins are cleared by the kidneys via tubular secretion. Whether novel endogenous measures of tubular secretion provide information about kidney, cardiovascular, and mortality risk is uncertain.

NCIRE-supported scientists, Drs. Michael Shlipak, Michelle Estrella, and Vasantha K Jotwani co-published a study that helps add clarity to the relationship between tubular secretion levels and risks with chronic kidney disease (CKD), cardiovascular disease (CVD), and mortality.

The research team used linear mixed-effect models to evaluate the association between the secretion score and change in eGFR, and Cox proportional hazards models were used to evaluate associations with CKD progression, CVD, and mortality. In multivariable analyses, lower secretion score was associated with faster estimated glomerular filtration rate decline and greater risk of CKD progression, CVD, and mortality.

After further adjustment for baseline eGFR and albuminuria, each 1-standard deviation lower secretion score was associated with faster eGFR decline (-0.65% per year; 95% CI, -0.84% to -0.46%), but not CKD progression (HR, 1.23; 95% CI, 0.96-1.58), CVD (HR, 1.02; 95% CI, 0.89-1.18), or mortality (HR, 0.90; 95% CI, 0.74-1.09). The secretion score association with eGFR decline appeared stronger in participants with baseline eGFR <45 mL/min/1.73 m2 (P for interaction < 0.001).

Michelle Estrella, MD, MHS is a Professor of Medicine and the Renal Section Chief at the San Francisco VA Medical Center.

Vasantha Jotwani, MD is a nephrologist and Associate Professor with the UCSF Department of Medicine who cares for patients with kidney disease at the San Francisco Veterans Affairs Health Care System. In research, Jotwani studies the causes and consequences of kidney disease in people with HIV, and she works on discovering new tests of kidney injury.

Congratulations to Dr. Alexander Smith for receiving the UCSF anti-racism RAP grant to study the impact of anti-AAPI hate incidents on the health and well-being of older AAPI

Anti-AAPI hate incidents have reached unprecedented levels in recent years. The Center for the Study of Hate and Extremism revealed that anti-Asian hate crime increased by 339 percent in 2021 compared to the year before, with New York, San Francisco, Los Angeles and other cities surpassing their record numbers in 2020, reaching unprecedented levels.

NCIRE-supported investigator Dr. Alexander Smith, along with several of his colleagues, was award the UCSF anti-racism Resource Allocation Program (RAP) grant to study the impact of anti-AAPI hate incidents on the health and well-being of older AAPI.

The UCSF Office of Research is committed to guiding equitable research conduct, building capacity for research on racism in biomedical research, and for supporting research using anti-racist and racial equity approaches. Toward this goal, the Research Development Office (RDO) has developed this anti-racism research seed grant program through its Resource Allocation Program (RAP). Base funding for this initiative is provided by the Academic Senate, School of Medicine’s Research Evaluation and Allocation Committee (REAC), and the UCSF Clinical and Translational Research Institute (CTSI).

Alexander Smith, MD, MS, MPH is a Staff Physician with the SF VA Health Care System, and Associate Professor of Medicine at UCSF. He co-developed ePrognosis, an online guide for older patients seeking to determine if they should be screened for cancer

https://geriatrics.ucsf.edu/news/drs-smith-li-and-kotwal-were-awarded-ucsf-anti-racism-rap-grant

https://rap.ucsf.edu/pilot-anti-racism-research

Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank

NCIRE-supported investigators Drs. Michael Shlipak and Michelle Estrella teamed up with researchers to identify differential associations of cystatin c and creatinine-based kidney function with risks of cardiovascular event and mortality among South Asians. The study surveyed 7738 South Asian UK BioBank participants without prevalent heart failure (HF) or atherosclerotic cardiovascular disease. The mean age was 53±8 years; 4085 (53%) were women. The team investigated associations of 4 eGFRcys and creatinine-based estimated glomerular filtration rate categories (<45, 45-59, 60-89, and ≥90 mL/min per 1.73 m2) with risks of all-cause mortality, incident HF, and incident atherosclerotic cardiovascular disease.

Michelle Estrella, MD, MHS is a Professor of Medicine and the Renal Section Chief at the San Francisco VA Medical Center.

Mike Steinman featured in NextAvenue Article

NCIRE-supported researcher Dr. Michael Steinman was featured in a NextAvenue.org article discussing the growing occurrence of polypharmacy, where a person regularly takes 5 or more prescription drugs, among older adults; and how a collective approach is advantageous to curb medication overload to mitigate adverse effects.

Michael Steinman, MD is a Staff Physician, Geriatrics, Palliative and Extended Care Service Line with the San Francisco VA Health Care System, and a Professor of Medicine at UCSF. He is also the co-director of the US Deprescribing Research Network, founded in 2019 with a grant from the National Institute on Aging to support and coordinate research into deprescribing.

Dr. Bruce Ovbiagele elected American Association for the Advancement of Science Fellow

The American Association for the Advancement of Science (AAAS) has elected Dr. Bruce Ovbiagele to the rank of AAAS Fellow, for his distinguished contributions to the field of vascular neurology, including health disparities and translation to underserved minorities and extensive contributions to mentoring and academic leadership.

Each year, the Council elects AAAS members whose “efforts on behalf of the advancement of science, or its applications, are scientifically or socially distinguished.” The Council elects Fellows deliberately and carefully to preserve the honor attached to this recognition. Election to AAAS is one of the highest honors in science and recognizes important contributions to research, as well as teaching, mentoring, fostering collaboration and promoting public understanding of science.

Bruce Ovbiagele, MD, MSc, MAS, MBA, MLS, FANA, is a NCIRE-supported researcher and Board member, as well as a vascular neurologist, clinical epidemiologist, and health equity scholar, with a focus on reducing the burden of stroke. He is Professor of Neurology and Associate Dean at UCSF, as well as Chief of Staff with the San Francisco VA Health Center System. Dr. Ovbiagele leads several funded programs focused on improving stroke outcomes among vulnerable and underserved populations, as well as mentoring early career scholars. He is also an elected member of the American Clinical and Climatological Association, Association of American Physicians, and National Academy of Medicine, and he is an elected fellow of the World Academy of Sciences, World Stroke Organization, American Academy of Neurology, American Heart Association, Royal College of Physicians, Royal Society of Public Health and African Academy of Science

Join NCIRE in congratulating Dr. Ovbiagele for this remarkable achievement!

Dr. Kristine Yaffe named 2022 Barnwell Awardee

NCIRE-supported researcher and Board member Kristine Yaffe, MD, has been named the 2022 John B. Barnwell Award recipient by the SF VA's Clinical Science Research and Development (CSR&D) service in recognition of her significant contributions as a leader in the field of Alzheimer's disease and related dementias (ADRD). She is the first woman to receive the award, which is CSR&D's highest honor given for scientific contributions that change clinical practice for veterans.

As an internationally recognized expert in the epidemiology of dementia and cognitive aging, Dr. Yaffe has served as the principal investigator on multiple grants from NIH, the U.S. Department of Defense, and several foundations, and delivered testimony as a subject expert to the U.S. Senate Special Committee on Aging. Her work focuses on the identification of modifiable risk factors—including cardiovascular and metabolic risk factors, sleep disturbances, and traumatic brain injury—and the critical role they play not just in late life, but across the entire lifespan. Her work has also provided important insight into the pathways that increase dementia risk.

The Barnwell Award recognizes senior VA Investigators who have achieved national and international acclaim for clinical research accomplishments in areas of prime importance to the VA’s research mission and who have also demonstrated a high level of clinical commitment to the patient population. More specifically, the award celebrates clinical researchers who have made notable sustained contributions resulting in better evaluation and treatment of conditions that are particularly important to veterans' health care.

Kristine Yaffe, MD, is the Roy and Marie Scola Endowed Chair and a professor of psychiatry, neurology, and epidemiology at UCSF, as well the Department of Psychiatry and Behavioral Sciences' vice chair for the Weill Institute for Neurosciences. She is also the chief of neuropsychiatry and director of the Memory Evaluation Clinic with the San Francisco VA Health Care System and director of the UCSF Center for Population Brain Health.

Join NCIRE in congratulating Dr. Yaffe for this remarkable achievement!

Smoking Prevalence Amongst Older Adults on the Decline

NCIRE-support investigators Drs. Ken Covinsky and John Boscardin co-published the article “The Epidemiology of Smoking in Older Adults: A National Cohort Study” in the Journal of General Internal Medicine. They found that smoking prevalence among older persons declined from 16% in 1998 to 11% in 2018 and over half of older smokers surviving to age 90 are able to successfully quit smoking. These findings highlight the need for continued aggressive efforts at tobacco cessation among older persons. This article was the last senior-authored article by Janine Cataldo, PhD, APRN-BC, FAAN, who died in 2021. Dr. Cataldo devoted her career to studying smoking and smoking cessation among older adults.

Ken Covinsky, MD, MPH is a clinician-researcher in the UCSF Division of Geriatrics. His research seeks to understand the factors that lead to disability in older persons and to improve the quality of life of those with older age disability and their caregivers. He holds the Edmund G. Brown, Sr Distinguished Professorship in Geriatrics and is Principal Investigator of the UCSF Older Americans Independence Center.

John Boscardin, PhD is a biostatistician with a joint appointment as Professor of Medicine and Epidemiology & Biostatistics. His primary roles with the Department of Medicine are as Director of the Statistical Laboratory in the UCSF Division of Geriatrics, Co-leader of the UCSF Pepper Center Data and Analysis Core, and Co-leader of the Analytics Core for the UCSF/Mount Sinai DEVELOP AD Research Program Project.

Learn More: https://pubmed.ncbi.nlm.nih.gov/36538157/

Functional and clinical needs of older hospice enrollees with coexisting dementia

NCIRE-supported researchers Drs. Alexander Smith and Kenneth Covinsky, along with colleagues at Mount Sinai, published a study in the Journal of American Geriatrics Society entitled: "Functional and clinical needs of older hospice enrollees with coexisting dementia." This study uses the National Health Aging and Trends Study (NHATS) linked to Medicare claims and finds that hospice enrollees with dementia coexisting with another terminal illness have high functional needs comparable to enrollees with principal hospice diagnoses of dementia, and high clinical needs comparable to hospice enrollees with no dementia.

Alexander Smith, MD, MPH, MS is a palliative medicine physician and Co-founder of the blog/podcast GeriPal.org and set of online prognosis calculators ePrognosis.org. His research is primarily focused on estimating and communicating prognosis for older adults with serious life limiting illnesses, including dementia.

Kenneth Covinsky, MD, MPH is a clinician-researcher in the UCSF Division of Geriatrics. His research seeks to understand the factors that lead to disability in older persons and to improve the quality of life of those with older age disability and their caregivers. He holds the Edmund G. Brown, Sr Distinguished Professorship in Geriatrics and is Principal Investigator of the UCSF Older Americans Independence Center.

End-of-life health care use among socially isolated and cognitively impaired older adults

Social isolation is common in the last years of life, especially among individuals with cognitive impairment (CI), but it is unknown if social isolation is related to end-of-life health care use.

In a nationally-representative cohort of 2,380 older adults in the last years of life, NCIRE-supported investigators Drs. Kristine Yaffe and Alex Smith, and their research colleagues examined if patterns of end-of-life health care use differed by level of social isolation or social isolation subscales including lack of household contacts, low social network interaction, and low community engagement.

The Study concluded that individuals with fewer household contacts had lower hospice use, and cognitively impaired individuals with low social network interaction had fewer end-of-life ED visits, hospitalizations, and ICU stays. Clinicians should consider mobilizing external support services to ensure access to goal-concordant care for older adults with limited end-of-life social contact when needed.

The study was published in the Journal of American Geriatrics Society.

Kristine Yaffe, MD is a NCIRE Board Member and Chief of NeuroPsychiatry and Director of the Memory Evaluation Clinic at SFVAHCS. She is also the Scola Endowed Chair and Vice Chair, Professor of Psychiatry, Neurology, and Epidemiology, and Director of the Center for Population Brain Health at UCSF.

Return to community living and mortality after moving to a long-term care facility: A nationally representative cohort study

Recent long-term care facility (LTCF) policy has focused on transitioning nursing home (NH) residents back to community settings, yet there is a lack of recent descriptions of this phenomenon and how it compares in assisted living (AL). NCIRE-supported researcher, Dr. Kenneth Covinsky, co-published a study that sought shine a light on this policy and the outcome for older adults.

Using the National Health and Aging Trends Study, Dr. Covinsky and his colleagues studied adults over age 65 who had moved from community living into an LTCF between 2011 and 2018. Their primary outcome was cumulative incidence of return to community living, with death as co-primary outcome and modeled as a competing risk, stratified by NH versus AL entry. They identified covariates (age, gender, race/ethnicity, dementia, activity limitations, and prior living arrangement) associated with return to community living through bivariate and multivariable logistic regression.

The study was published in the Journal of American Geriatrics Society.

NCIRE-supported Investigators’ research paper receives the Journal of Geriatric Oncology's Dr. Arti Hurria Best Paper Award for 2021-2022

NCIRE-supported investigators Drs. Louise Walter, Alex Smith, Carling Ursem co-published a paper that received the Journal of Geriatric Oncology's Dr. Arti Hurria Best Paper Award for 2021-2022.

The paper, “You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology”, posited that shared decision making (SDM) is especially important for older adults with cancer given the risks of over- and undertreatment, uncertainty regarding benefits/harms worsened by research underrepresentation, and individual preferences. The research team aimed to adapt the Best Case/Worst Case (BC/WC) communication tool, which improves SDM in geriatric surgery, to geriatric oncology.

Congratulations to our supported investigators!

Louise Walter, MD is a NCIRE Board Member and Professor of Medicine and Chief of the Division of Geriatrics at SFVAHCS and UCSF. Dr. Walter is a practicing Geriatrician in the SFVAHCS Geriatrics Clinic, as well as a clinician-researcher who is an international leader in evaluating the real-world risks and benefits of cancer screening in older patients.

Carling Ursem, MD is an Assistant Professor with the UCSF Division Of Hematology and Oncology at the SF VA Medical Center, with an expert focus on Gastrointestinal & Genitourinary Oncology and Geriatric Oncology.

Post-traumatic stress disorder and risk for hospitalization and death following COVID-19 infection

Post-traumatic stress disorder (PTSD) is associated with an increased risk for physical illnesses and early mortality. However, it is not known if it also increases the risk for adverse outcomes of coronavirus disease 2019 (COVID-19).

In a retrospective cohort study, published in the medical journal Translational Psychiatry, NCIRE-supported researchers, Drs. Karen Seal and Thomas Neylan, examined associations of PTSD and other psychiatric disorders with risk for hospitalization and death in the 60 days following a COVID-19 infection in 228,367 U.S. Department of Veteran Affairs patients who tested positive for COVID-19 between February 2020 and August 2021 (age m = 60.6, 89.5% male).

In this large-scale study of VA patients, individuals with PTSD, and other psychiatric disorders, had heightened vulnerability to severe adverse outcomes of COVID-19; thus, individuals with PTSD should also be considered at higher risk for severe COVID-19 outcomes, and potentially prioritized for vaccination, screening, and early treatment intervention for COVID-19.

Karen Seal, MD, is a Professor of Medicine and Psychiatry in Residence at the University of California, San Francisco (UCSF). Based at the San Francisco VA Health Care System (SFVAHCS), she serves as Chief of the Integrative Health Service.

Thomas Neylan, MD, is a Professor, In Residence in the Department of Psychiatry at the University of California, San Francisco. He is the Director of the Posttraumatic Stress Disorders (PTSD) Clinic and the Stress and Health Research Program at the San Francisco Veterans Affairs Medical Center.

Learn more: https://www.nature.com/articles/s41398-022-02156-w

Researchers Address Racial Imbalances in Alzheimer’s Study: $147M Grant Boosts Efforts to Recruit More Blacks, Latinx, Asians, American Indians

The Northern California Institute for Research and Education, which partners with UC San Francisco and the San Francisco VA Medical Center, has been awarded a five-year, $147 million grant that will expand diversity among Alzheimer’s disease research participants for the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

In the fourth iteration of this study, ADNI4, researchers will focus on recruiting ethnoculturally diverse participants by using a community-engaged approach with recruiters in communities, digital marketing and social media campaigns. Approximately 50 percent to 60 percent of new enrollees will be from underrepresented groups, such as Black, Latinx, Asian, Pacific Islander, American Indian, as well as people with a high school education or less.

Funding for the upcoming phase of the study, ADNI4, is approximately double that of the study’s third phase, enabling researchers to expand their current participant pool from more than 1,000 to about 1,500 people. At least half of the participants will come from underrepresented populations, in an effort to make research findings more generalizable for all patients with Alzheimer’s disease.

ADNI was launched in 2004 to identify and validate the imaging, genetic and biochemical biomarkers in the early detection and tracking of Alzheimer’s disease -- the most common form of dementia -- as well as to support advances in preventing and treating the disorder through new diagnostic methods.

The project leader is Michael Weiner, MD, professor of radiology, medicine and neurology at UCSF and the principal investigator of ADNI, with 60 sites in the United States and Canada. ADNI is one of the first public-private partnerships funded in part by the National Institutes of Health’s National Institute on Aging to study the neurodegenerative disorder.

Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System

Novel therapies for type 2 diabetes can reduce the risk of cardiovascular disease and chronic kidney disease progression. The equitability of these agents' prescription across racial and ethnic groups has not been well-evaluated.

NCIRE-supported researchers, Drs. Michael Shlipak and Michelle Estrella, and their colleagues investigated the differences in the prescription of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) among adult patients with type 2 diabetes by racial and ethnic groups.

The study found that among patients with type 2 diabetes in the Veterans Health Administration system during 2019 and 2020, prescription rates of SGLT2i and GLP-1 RA medications were low, and individuals of several different racial groups and those of Hispanic ethnicity had statistically significantly lower odds of receiving prescriptions for these medications compared with individuals of White race and non-Hispanic ethnicity. Further research is needed to understand the mechanisms underlying these differences in rates of prescribing and the potential relationship with differences in clinical outcomes.

The study was published in The Journal of the American Medical Association (JAMA).

Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults: An Ancillary Analysis of the LIFE Study Randomized Clinical Trial

Observational evidence suggests that higher physical activity is associated with slower kidney function decline; however, to the best of knowledge, no large trial has evaluated whether activity and exercise can ameliorate kidney function decline in older adults.

NCIRE-supported investigator Michael Shlipak, MD, MPH co-published a study that sough to evaluate whether a moderate-intensity exercise intervention can affect the rate of estimated glomerular filtration rate per cystatin C (eGFRCysC) change in older adults.

The study, which included the analysis of a randomized clinical trial, showed that when compared with health education, a physical activity and exercise intervention slowed the rate of decline in eGFRCysC among community-dwelling sedentary older adults. Clinicians should consider targeted recommendation of physical activity and moderate-intensity exercise for older adults as a treatment to slow decline in eGFRCysC.

This study was published in The Journal of the American Medical Association (JAMA) Internal Medicine.

Michael Shlipak, MD, MPH is an Associate Chief of Medicine for Research Development at the SF VA Health Center System, Professor of Medicine, Epidemiology and Biostatistics at UC San Francisco, and co-founder and Scientific Director of the Kidney Health Research Collaborative.

Genetics professionals are key to the integration of genetic testing within the practice of frontline clinicians

With genetic tests have becoming more widely available, NCIRE-supported researchers sought to understand the use of genetic tests in the practice of frontline clinicians within the United States Department of Veterans Affairs (VA).

Drs. Maren Scheuner, Katherine Hoggatt, Mary Whooley and their colleagues administered a web-based survey to clinicians at 20 VA facilities. Physicians, nurse practitioners, physician assistants, and pharmacists were eligible. They excluded genetics providers and clinicians not seeing patients. The research team used multiple logistic regression to evaluate the associations between clinician characteristics and experience with genetics.

Their study revealed that most VA clinicians don't feel prepared to use genetic tests. Those with genetic testing experience are more likely to consult genetics providers. The demand for genetics providers should increase as frontline clinicians use genetic tests in their practice.

This study was published in Genetics in Medicine, a journal of the American College of Medical Genetics and Genomics.

Development and validation of novel multimorbidity indices for older adults

Measuring multimorbidity in claims data is used for risk adjustment and identifying populations at high risk for adverse events. Multimorbidity indices such as Charlson and Elixhauser scores have important limitations. NCIRE-supported researchers sought to create a better method of measuring multimorbidity using claims data by incorporating geriatric conditions, markers of disease severity, and disease-disease interactions, and by tailoring measures to different outcomes.

In a study published in the Journal of the American Geriatrics Society, Drs. Michael Steinman, Sei Lee, Kenneth Covinsky, W. John Boscardin and their colleagues developed a new series of claims-based multimorbidity measures that were modestly better at predicting hospitalization and functional decline than several legacy indices, and death.

Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines

A cohort of NCIRE-supported investigators posed the question: What is the incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines?

The retrospective cohort study, published in the JAMA Network, included 1,610,719 participants receiving care at Veterans Health Administration facilities, followed up for 24 weeks (July 1, 2021, to May 30, 2022) after completing a COVID-19 vaccination series and booster. Overall, the incidence of hospitalization with COVID-19 pneumonia or death was 8.9 per 10, 000 persons. The meant that in a US cohort, there was a low incidence of hospitalization with COVID-19 pneumonia or death following vaccination and booster during a period of Delta and Omicron variant predominance.

The NCIRE-supported researchers involved in the study included Katherine Hoggatt, PhD; W. John Boscardin, PhD; Amy Byers, PhD; Phyllis C. Tien, MD; Salomeh Keyhani, MD, MPH; Joseph Wong, MD; and Tristin A. Moss-Vaszquesz, BA.

The study was published in the Journal of the American Medical Association (JAMA).

Improving multiparametric MR-transrectal ultrasound guided fusion prostate biopsies with hyperpolarized 13 C pyruvate metabolic imaging: A technical development study

NCIRE-supported investigator Matthew Cooperberg, MD, MPH co-published a study that sought to develop techniques and establish a workflow using hyperpolarized carbon-13 (13 C) MRI and the pyruvate-to-lactate conversion rate (kPL ) biomarker to guide MR-transrectal ultrasound fusion prostate biopsies.

The study demonstrated the safety and technical feasibility of integrating hyperpolarized 13 C metabolic targeting into routine 1 H-mpMRI and transrectal ultrasound fusion biopsy workflows, evaluated via 5 men (median age 71 years, prostate-specific antigen 8.4 ng/mL, Cancer of the Prostate Risk Assessment score 2) on active surveillance undergoing integrated scan and subsequent biopsies.

The study was published in the medical journal, Magnetic Resonance in Medicine.

Dr. Cooperberg is a Professor of Urology and Epidemiology & Biostatistics; Helen Diller Family Chair in Urology; Chief of Urology at San Francisco VA Health Center System.

Dr. Michelle Estrella receives ASN Distinguished Mentor Award

The American Society of Nephrology (ASN) recognized NCIRE-supported scientist Michelle Estrella, MD with its Distinguished Mentor Award.

The award recognizes individuals who have made contributions to the kidney community through the mentorship and development of other clinicians or researchers; and those who inspire trainees to pursue nephrology and become leaders in the transformation of healthcare through innovations in research, education, and practice.

Dr. Karen M. Warburton, MD of UVA Health was also recognized with this year’s award.

Michelle Estrella, MD, MHS is a Professor of Medicine and the Renal Section Chief at the San Francisco VA Medical Center.

Dr. Judith M. Ford Named 2022 Middleton Awardee

We are proud to announce that NCIRE-supported researcher Dr. Judith M. Ford has been named a 2022 Middleton Awardee! The William S. Middleton Award is the highest honor conferred by the VA Biomedical Laboratory Research and Development service, recognizing outstanding achievement in biomedical research.

Dr. Ford is recognized for her translational research in psychiatry, which has transformed the understanding of psychotic illnesses in Veterans. She is credited with explaining the basic neural mechanism that enables animals to distinguish between "self-generated" and "other-generated" sensations. This finding facilitated groundbreaking research that found people with schizophrenia demonstrate altered responses to self-generated sensations like sound and speech, due to an inability to predict these sensations.

Sensations that are not predicted may be attributed to external sources. In this way, thoughts may become audible. Her work has reassured patients and their families that their symptoms have a neuro-biological basis. Dr. Ford's research has provided fundamental insights into the pathophysiology of schizophrenia-spectrum disorders. She is a visionary scientist whose discoveries have assisted Veterans and others diagnosed with mental health disorders.

Dr. Ford is a research career scientist at the San Francisco VA Medical Center and codirects the Brain Imaging and Electroencephalography (EEG) Laboratory at the University of California in San Francisco. She was the former director of the Schizophrenia Biological Research Center at the VA Connecticut Healthcare System in West Haven.

Join NCIRE in congratulating Dr. Ford for this remarkable achievement!

More Research News